ArticleNucleic acids research2026
YqeK governs the acquisition and removal of nucleoside tetraphosphate caps in Firmicutes.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Loss of the ApJournal of bacteriology · 2026Article
- Molecular insights into the promiscuous ApThe Journal of biological chemistry · 2026Article
- Omnivore RNA pyrophosphatase: a versatile enzyme that efficiently removes diverse protecting groups from the 5' end of RNA.Nucleic acids research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Nucleoside tetraphosphate (Np4) caps have heretofore been reported in only one bacterial species: the model Gram-negative organism Escherichia coli, where RNAs acquire this epitranscriptomic modification during disulfide stress or when the dinucleoside tetraphosphate (Np4A) hydrolase ApaH is eliminated by mutation. Here, we show that caps of this kind also appear on RNA 5' ends in the prototypical Gram-positive organism Bacillus subtilis upon deleting the yqeK gene, which encodes an unrelated Np4A hydrolase. Present on diverse mRNAs irrespective of the identity of their 5'-terminal nucleotide, these caps are acquired in B. subtilis at least in part by Np4A incorporation at the 5' end of nascent transcripts during transcription initiation. YqeK suppresses Np4 capping by functioning both as an Np4A hydrolase that reduces the availability of Np4As for incorporation into RNA and as a decapping enzyme that can deprotect Np4-capped mRNA in B. subtilis by converting those caps to 5'-terminal diphosphates, thereby accelerating capped mRNA degradation. Disulfide stress increases Np4 capping in B. subtilis ∆yqeK mutants. Moreover, the elevated level of Np4 capping in these mutants is accompanied by an increased ability of B. subtilis to survive disulfide stress, suggesting a physiologically protective impact of Np4As and/or Np4 capping under these conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.